https://www.opindia.com/2021/03/bharat-biotechs-covaxin-81-efficacy-phase-3-trials-with-25800-subjects-completed/
Bharat Biotech's Covaxin shows 81% efficacy, phase 3 trials with 25,800 subjects completed